Clinical Trial Update: LutrePulse Hypogonadotropic Hypogonadism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for LutrePulse addressing hypogonadotropic hypogonadism presenting as primary amenorrhea; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amenorrhea
• Hypogonadotropic Hypogonadism

Drugs mentioned

• LutrePulse

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Primary Amenorrhea With Hypogonadotropic Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2021-03-03